- Hilleman CEO on why new cholera vaccine could be "high impact"
- Valneva builds on traveler's vaccine franchise with €45m Dukoral buy
- US Capitol Capsule: Fauci: Ebola must be a 'shake the cage moment'
- WHO: Best scenario puts Ebola vaccine late Q1 2015
ANALYSIS Other Informa Analysis
COMMENT Other Informa Comment
- Interview: building on Spiriva – Boehringer Ingelheim's Allan Hillgrove
- PROFILE: Mundipharma's Antony Mattessich on his journey from terror expert to pharma, contrarian-style
JOB OF THE WEEK Promote your job vacancy